Pulmonary adenocarcinoma: A renewed entity in 2011
Authors:
Open Access
- 31 October 2011
- journal article
- review article
- Published by Wiley in Respirology
- Vol. 17 (1) , 50-65
Abstract
Lung cancer, of which non‐small‐cell lung cancer comprises the majority, is the leading cause of cancer‐related deaths in the United States and worldwide. Lung adenocarcinomas are a major subtype of non‐small‐cell lung cancers, are increasing in incidence globally in both males and females and in smokers and non‐smokers, and are the cause for almost 50% of deaths attributable to lung cancer. Lung adenocarcinoma is a tumour with complex biology that we have recently started to understand with the advent of various histological, transcriptomic, genomic and proteomic technologies. However, the histological and molecular pathogenesis of this malignancy is still largely unknown. This review will describe advances in the molecular pathology of lung adenocarcinoma with emphasis on genomics and DNA alterations of this disease. Moreover, the review will discuss recognized lung adenocarcinoma preneoplastic lesions and current concepts of the early pathogenesis and progression of the disease. We will also portray the field cancerization phenomenon and lineage‐specific oncogene expression pattern in lung cancer and how both remerging concepts can be exploited to increase our understanding of lung adenocarcinoma pathogenesis for subsequent development of biomarkers for early detection of adenocarcinomas and possibly personalized prevention.Keywords
This publication has 147 references indexed in Scilit:
- Do all lung adenocarcinomas follow a stepwise progression?Lung Cancer, 2011
- Suppression of lung adenocarcinoma progression by Nkx2-1Nature, 2011
- Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancerBritish Journal of Cancer, 2011
- A small-cell lung cancer genome with complex signatures of tobacco exposureNature, 2009
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasNature Genetics, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingNature Genetics, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989